DocGo (DCGO) Financials

DocGo logo
$0.18 -0.01 (-3.53%)
Closing price 04:00 PM Eastern
Extended Trading
$0.18 0.00 (-0.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for DocGo

Annual Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-14 24 35 6.86 20 -182
Consolidated Net Income / (Loss)
-15 19 31 10 13 -196
Net Income / (Loss) Continuing Operations
-15 19 31 10 13 -196
Total Pre-Tax Income
-15 20 23 16 28 -187
Total Operating Income
-15 15 22 15 29 -178
Total Gross Profit
31 110 155 195 214 99
Total Revenue
94 319 441 624 617 322
Operating Revenue
94 319 441 624 617 322
Total Cost of Revenue
63 209 286 429 403 223
Operating Cost of Revenue
63 209 286 429 403 223
Total Operating Expenses
46 94 133 180 185 277
Selling, General & Admin Expense
35 75 103 137 139 133
Marketing Expense
0.75 4.76 4.76 2.80 1.51 1.42
Research & Development Expense
1.19 3.32 5.38 11 12 14
Depreciation Expense
5.51 7.51 11 16 16 16
Impairment Charge
- 0.00 - 0.00 0.00 89
Other Special Charges / (Income)
3.75 3.91 8.78 13 17 24
Total Other Income / (Expense), net
0.13 4.44 0.95 1.24 -0.94 -9.47
Interest & Investment Income
0.00 -0.07 0.77 1.34 -2.25 -1.79
Other Income / (Expense), net
0.33 5.13 0.18 -0.10 1.31 -7.67
Income Tax Expense
0.17 0.62 -7.96 6.24 14 8.87
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.44 -4.56 -3.84 3.19 -6.63 -14
Basic Earnings per Share
($0.25) $0.30 $0.34 $0.07 $0.20 ($1.84)
Weighted Average Basic Shares Outstanding
58.37M 80.29M 101.23M 103.51M 102.40M 99.07M
Diluted Earnings per Share
($0.25) $0.25 $0.34 $0.06 $0.18 ($1.84)
Weighted Average Diluted Shares Outstanding
58.37M 94.86M 102.98M 105.62M 109.42M 99.07M
Weighted Average Basic & Diluted Shares Outstanding
- 100.17M 102.51M 104.17M 101.98M 98.75M

Quarterly Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
11 6.53 5.50 -3.26 -9.41 -11 -28 -134 -15 -16 -17
Consolidated Net Income / (Loss)
11 5.86 4.55 -7.65 -11 -13 -30 -142 -17 -18 -18
Net Income / (Loss) Continuing Operations
11 5.86 4.55 -7.65 -11 -13 -30 -142 -17 -18 -18
Total Pre-Tax Income
16 9.57 9.03 -6.58 -15 -18 -43 -112 -17 -18 -18
Total Operating Income
16 10 10 -7.47 -14 -17 -42 -105 -19 -18 -17
Total Gross Profit
192 165 139 -157 96 80 71 -149 76 73 73
Total Revenue
192 165 139 121 96 80 71 75 76 73 73
Operating Revenue
192 165 139 121 96 80 71 75 76 73 73
Total Cost of Revenue
0.00 0.00 0.00 278 0.00 0.00 0.00 223 0.00 0.00 0.00
Total Operating Expenses
176 155 129 -150 110 98 113 -44 94 91 91
Selling, General & Admin Expense
40 35 29 35 33 31 30 39 31 30 29
Marketing Expense
0.34 0.39 0.38 0.40 0.33 0.37 0.38 0.34 0.37 0.42 0.44
Research & Development Expense
2.39 2.37 3.15 3.69 3.64 2.96 3.19 3.77 3.71 3.45 4.03
Depreciation Expense
4.18 4.20 4.18 3.32 3.76 3.98 3.97 3.95 2.65 2.69 2.64
Other Operating Expenses / (Income)
125 109 89 - 65 55 53 - 52 51 49
Impairment Charge
- - 0.00 - - - 17 - - - 0.00
Other Special Charges / (Income)
4.31 4.01 3.30 5.53 4.21 4.35 5.73 9.53 5.03 4.03 5.74
Total Other Income / (Expense), net
-0.15 -0.58 -1.10 0.90 -0.81 -0.44 -1.19 -7.03 2.03 -0.01 -0.92
Interest & Investment Income
-0.45 -0.58 -0.59 -1.00 -0.47 -0.48 -0.25 -0.60 -0.10 -0.10 -0.06
Other Income / (Expense), net
0.30 -0.00 -0.52 1.53 -0.34 0.05 -0.95 -6.43 2.13 0.08 -0.86
Income Tax Expense
5.12 3.71 4.49 1.07 -3.72 -4.63 -14 31 0.02 0.06 0.08
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.62 -0.67 -0.95 -4.38 -1.67 -2.13 -1.89 -8.27 -1.94 -2.17 -1.69
Basic Earnings per Share
$0.11 $0.06 $0.05 ($0.02) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15) ($0.16) ($0.17)
Weighted Average Basic Shares Outstanding
103.82M 101.84M 102.07M 102.40M 101.59M 98.93M 97.81M 99.07M 98.75M 98.80M 98.94M
Diluted Earnings per Share
$0.10 $0.06 $0.05 ($0.03) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15) ($0.16) ($0.17)
Weighted Average Diluted Shares Outstanding
108.51M 106.32M 106.29M 109.42M 101.59M 98.93M 97.81M 99.07M 98.75M 98.80M 98.94M
Weighted Average Basic & Diluted Shares Outstanding
101.57M 102.32M 102.05M 101.98M 99.10M 97.81M 97.81M 98.75M 98.78M 98.93M 98.99M

Annual Cash Flow Statements for DocGo

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-17 145 -15 -92 35 -55
Net Cash From Operating Activities
-11 -1.95 29 -64 70 34
Net Cash From Continuing Operating Activities
-11 -1.95 29 -64 70 34
Net Income / (Loss) Continuing Operations
-15 19 31 10 13 -196
Consolidated Net Income / (Loss)
-15 19 31 10 13 -196
Depreciation Expense
1.87 2.31 4.11 4.83 5.61 4.86
Amortization Expense
3.63 4.76 6.45 12 10 10
Non-Cash Adjustments To Reconcile Net Income
2.24 0.60 11 26 28 124
Changes in Operating Assets and Liabilities, net
-3.61 -29 -23 -117 13 91
Net Cash From Investing Activities
-6.04 -8.59 -38 -30 -11 -39
Net Cash From Continuing Investing Activities
-6.04 -8.59 -38 -30 -11 -39
Purchase of Property, Plant & Equipment
-4.36 -4.81 -3.20 -7.31 -3.61 -4.54
Acquisitions
-1.95 -3.81 -35 -23 -2.31 -19
Purchase of Investments
- - - 0.00 0.00 -29
Sale of Property, Plant & Equipment
0.28 0.07 0.00 0.75 0.27 0.20
Sale and/or Maturity of Investments
- - - 0.00 0.00 13
Other Investing Activities, net
0.00 -0.05 - - -5.00 0.00
Net Cash From Financing Activities
-0.81 155 -6.18 1.12 -24 -51
Net Cash From Continuing Financing Activities
-0.81 155 -6.18 1.12 -24 -51
Repayment of Debt
-0.80 -8.60 -3.94 -4.30 -40 -30
Repurchase of Common Equity
0.00 0.00 -3.75 0.00 -14 -11
Payment of Dividends
- -20 0.00 0.00 -3.14 -0.18
Issuance of Debt
0.00 8.00 0.00 25 45 0.26
Other Financing Activities, net
-1.51 -2.66 -0.55 -20 -12 -10
Cash Interest Paid
0.61 0.32 0.76 0.85 2.14 1.71
Cash Income Taxes Paid
0.12 0.62 1.51 10 5.88 6.48

Quarterly Cash Flow Statements for DocGo

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-13 27 23 -1.24 -4.28 5.50 -31 -26 -5.67 -15 -7.85
Net Cash From Operating Activities
-11 37 31 13 9.22 34 1.66 -10 -4.66 -9.24 -3.62
Net Cash From Continuing Operating Activities
-11 37 31 13 9.22 34 1.66 -10 -4.66 -9.24 -3.62
Net Income / (Loss) Continuing Operations
11 5.86 4.55 -7.65 -11 -13 -30 -142 -17 -18 -18
Consolidated Net Income / (Loss)
11 5.86 4.55 -7.65 -11 -13 -30 -142 -17 -18 -18
Depreciation Expense
1.43 1.48 1.37 1.32 1.22 1.21 1.25 1.18 1.27 1.24 1.16
Amortization Expense
2.75 2.73 2.80 2.00 2.54 2.62 2.65 2.67 1.30 1.37 1.36
Non-Cash Adjustments To Reconcile Net Income
5.38 4.10 4.36 14 6.14 6.16 23 89 5.02 3.80 4.60
Changes in Operating Assets and Liabilities, net
-31 23 18 3.25 10 37 4.78 39 4.45 2.34 7.55
Net Cash From Investing Activities
-1.70 -2.09 -1.51 -5.57 -5.29 -21 1.10 -13 1.66 -3.88 -1.18
Net Cash From Continuing Investing Activities
-1.70 -2.09 -1.51 -5.57 -5.29 -21 1.10 -13 1.66 -3.88 -1.18
Purchase of Property, Plant & Equipment
-0.95 -1.20 -0.79 -0.89 -1.03 -0.70 -0.88 -1.50 -0.43 -0.32 -2.16
Acquisitions
-0.77 -0.94 -0.82 0.23 -4.36 -0.87 -0.69 -13 -0.67 -0.83 1.49
Purchase of Investments
- - - - 0.00 - -2.52 -3.87 -1.73 -5.75 -6.35
Sale and/or Maturity of Investments
- - - - 0.00 - 5.16 5.68 4.46 3.00 5.81
Net Cash From Financing Activities
-0.88 -8.07 -7.35 -7.86 -8.52 -7.38 -33 -1.86 -2.46 -1.66 -3.10
Net Cash From Continuing Financing Activities
-0.88 -8.07 -7.35 -7.86 -8.52 -7.38 -33 -1.86 -2.46 -1.66 -3.10
Repayment of Debt
-41 -1.07 -1.09 3.09 -0.00 -0.00 -30 -0.01 -0.01 -0.01 -0.01
Payment of Dividends
- - -1.85 -1.04 0.00 - -0.18 - -1.02 - -1.14
Other Financing Activities, net
-0.02 -1.84 -3.11 -7.22 -2.76 -2.30 -3.11 -1.85 -1.43 -1.65 -1.94
Effect of Exchange Rate Changes
-0.10 0.03 0.58 - 0.32 0.65 -0.65 - -0.21 0.14 0.05
Cash Interest Paid
0.63 0.65 0.79 0.07 0.56 0.91 0.89 -0.65 0.05 0.55 0.25
Cash Income Taxes Paid
0.56 0.81 5.17 0.71 1.91 4.19 0.55 -0.17 0.02 0.15 0.12

Annual Balance Sheets for DocGo

This table presents DocGo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
100 310 393 490 456 217
Total Current Assets
58 256 271 339 304 152
Cash & Equivalents
32 176 157 59 89 51
Accounts Receivable
25 78 103 262 211 93
Prepaid Expenses
1.15 2.11 6.27 17 4.01 4.79
Other Current Assets
- 0.00 - - 0.34 3.70
Plant, Property, & Equipment, net
9.11 13 21 17 15 15
Total Noncurrent Assets
33 41 101 135 136 50
Long-Term Investments
0.00 0.59 0.60 - 0.00 16
Noncurrent Note & Lease Receivables
7.00 9.31 9.04 12 15 17
Intangible Assets
11 11 23 38 26 0.00
Noncurrent Deferred & Refundable Income Taxes
- - 9.96 12 8.42 0.54
Other Noncurrent Operating Assets
8.36 12 19 26 21 15
Other Noncurrent Nonoperating Assets
- - - - 18 1.47
Total Liabilities & Shareholders' Equity
100 310 393 490 456 217
Total Liabilities
33 83 114 185 140 91
Total Current Liabilities
23 58 100 170 122 67
Short-Term Debt
0.66 0.63 0.66 25 35 3.09
Accounts Payable
5.08 17 22 20 28 11
Accrued Expenses
14 35 32 91 50 43
Other Current Liabilities
3.50 4.73 42 34 8.57 10
Total Noncurrent Liabilities
9.73 25 14 15 19 24
Long-Term Debt
0.59 1.30 1.24 0.04 0.01 0.18
Other Noncurrent Operating Liabilities
9.14 23 13 15 19 24
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
67 227 279 305 315 126
Total Preferred & Common Equity
55 220 273 301 321 144
Total Common Equity
55 220 273 301 321 144
Common Stock
142 283 301 321 321 325
Retained Earnings
-87 -64 -29 -21 -1.40 -184
Accumulated Other Comprehensive Income / (Loss)
-0.05 -0.03 0.74 1.48 1.22 2.39
Noncontrolling Interest
12 7.48 5.70 4.38 -5.74 -18

Quarterly Balance Sheets for DocGo

This table presents DocGo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
390 420 491 488 494 431 408 354 209 187 174
Total Current Assets
234 267 335 329 328 263 237 190 138 120 110
Cash & Equivalents
109 53 41 66 89 79 104 73 36 25 19
Accounts Receivable
118 207 283 258 234 179 123 107 94 86 83
Prepaid Expenses
6.79 6.90 11 5.14 5.15 4.77 9.65 4.73 5.28 4.40 4.05
Other Current Assets
- - - - - - - 5.12 3.25 3.94 3.57
Plant, Property, & Equipment, net
22 22 16 16 15 15 14 14 14 13 11
Total Noncurrent Assets
134 131 139 143 150 153 157 149 57 54 53
Long-Term Investments
0.39 0.45 0.47 0.55 0.63 - 20 18 13 16 16
Noncurrent Note & Lease Receivables
8.96 8.57 13 14 15 17 18 17 18 17 16
Intangible Assets
38 39 37 36 35 27 27 18 0.64 1.41 1.90
Noncurrent Deferred & Refundable Income Taxes
11 8.91 12 14 17 12 17 31 0.81 0.56 0.58
Other Noncurrent Operating Assets
27 27 29 31 35 47 21 21 14 13 12
Other Noncurrent Nonoperating Assets
- - - - - - 4.39 4.25 11 6.94 5.21
Total Liabilities & Shareholders' Equity
390 420 491 488 494 431 408 354 209 187 174
Total Liabilities
106 128 176 170 169 129 121 93 98 91 95
Total Current Liabilities
92 113 160 154 150 108 100 74 77 72 80
Short-Term Debt
19 14 30 30 30 30 30 0.05 8.15 7.95 11
Accounts Payable
6.69 8.95 26 31 35 21 10 8.05 14 14 17
Accrued Expenses
35 59 70 63 60 41 45 51 45 40 42
Other Current Liabilities
32 32 34 30 25 16 15 15 10 10 10
Total Noncurrent Liabilities
15 15 15 16 19 21 20 20 21 19 15
Long-Term Debt
1.58 2.04 0.03 0.03 0.02 0.00 0.00 0.20 0.17 0.16 0.15
Other Noncurrent Operating Liabilities
13 13 15 16 19 21 20 19 21 19 15
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
284 292 315 318 325 302 288 261 111 96 79
Total Preferred & Common Equity
280 288 311 315 325 309 297 271 132 119 105
Total Common Equity
280 288 311 315 325 309 297 271 132 119 105
Common Stock
312 316 320 317 321 318 317 318 329 331 334
Retained Earnings
-34 -29 -10 -3.64 1.86 -11 -22 -50 -199 -214 -231
Accumulated Other Comprehensive Income / (Loss)
1.39 0.81 1.34 1.38 2.31 1.72 2.72 2.43 2.25 2.17 1.96
Noncontrolling Interest
4.09 3.95 3.75 2.83 -0.31 -7.41 -9.55 -9.87 -21 -23 -26

Annual Metrics And Ratios for DocGo

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
14,375,000.00 100,069,438.00 - - - 97,813,372.00
DEI Adjusted Shares Outstanding
14,375,000.00 100,069,438.00 - - - 97,813,372.00
DEI Earnings Per Adjusted Shares Outstanding
-1.00 0.24 - - - -1.86
Growth Metrics
- - - - - -
Revenue Growth
0.00% 238.74% 38.21% 41.72% -1.24% -47.74%
EBITDA Growth
0.00% 408.92% 18.23% -3.66% 46.19% -471.31%
EBIT Growth
0.00% 241.97% 7.46% -32.07% 100.60% -719.13%
NOPAT Growth
0.00% 244.04% 97.99% -68.48% 48.77% -1,002.22%
Net Income Growth
0.00% 229.60% 60.29% -67.32% 32.96% -1,569.75%
EPS Growth
0.00% 200.00% 36.00% -82.35% 200.00% -1,122.22%
Operating Cash Flow Growth
0.00% 81.72% 1,582.47% -322.45% 209.52% -50.86%
Free Cash Flow Firm Growth
0.00% 0.00% -1,750.53% -242.02% 120.76% 36.86%
Invested Capital Growth
0.00% 47.70% 132.49% 120.48% -5.54% -74.96%
Revenue Q/Q Growth
0.00% 0.00% -2.70% 16.95% -11.28% -12.47%
EBITDA Q/Q Growth
0.00% 0.00% -39.53% 71.22% -29.79% -158.82%
EBIT Q/Q Growth
0.00% 0.00% -51.15% 367.04% -37.73% -130.29%
NOPAT Q/Q Growth
0.00% 0.00% -18.71% -38.21% -53.68% -119.99%
Net Income Q/Q Growth
0.00% 0.00% -29.92% 9.18% -53.93% -218.40%
EPS Q/Q Growth
0.00% 0.00% -98.18% -45.45% -33.33% -260.78%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.22% 4.20% 36.49% -40.46%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -5.77% 52.60% 35.11%
Invested Capital Q/Q Growth
0.00% 0.00% 14.13% 6.71% -3.36% -63.30%
Profitability Metrics
- - - - - -
Gross Margin
33.32% 34.43% 35.12% 31.30% 34.64% 30.65%
EBITDA Margin
-9.48% 8.65% 7.39% 5.03% 7.44% -52.87%
Operating Margin
-15.68% 4.82% 4.96% 2.41% 4.65% -55.26%
EBIT Margin
-15.33% 6.43% 5.00% 2.40% 4.86% -57.64%
Profit (Net Income) Margin
-15.73% 6.02% 6.98% 1.61% 2.17% -60.95%
Tax Burden Percent
101.14% 96.89% 134.95% 61.67% 48.15% 104.73%
Interest Burden Percent
101.42% 96.65% 103.51% 108.97% 92.51% 100.97%
Effective Tax Rate
0.00% 3.11% -34.95% 38.33% 51.85% 0.00%
Return on Invested Capital (ROIC)
-28.87% 33.57% 33.52% 4.71% 5.24% -82.08%
ROIC Less NNEP Spread (ROIC-NNEP)
-14.52% 29.38% 32.75% 3.91% 6.21% 22.35%
Return on Net Nonoperating Assets (RNNOA)
6.76% -20.52% -21.37% -1.27% -0.94% -6.96%
Return on Equity (ROE)
-22.11% 13.05% 12.15% 3.44% 4.31% -89.05%
Cash Return on Invested Capital (CROIC)
0.00% -4.95% -46.17% -70.47% 10.94% 37.80%
Operating Return on Assets (OROA)
-14.40% 10.00% 6.26% 3.38% 6.34% -55.21%
Return on Assets (ROA)
-14.77% 9.36% 8.75% 2.27% 2.82% -58.38%
Return on Common Equity (ROCE)
-18.16% 12.19% 11.84% 3.38% 4.32% -93.87%
Return on Equity Simple (ROE_SIMPLE)
-26.91% 8.73% 11.25% 3.34% 4.16% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 15 29 9.28 14 -125
NOPAT Margin
-10.98% 4.67% 6.69% 1.49% 2.24% -38.68%
Net Nonoperating Expense Percent (NNEP)
-14.34% 4.19% 0.78% 0.80% -0.97% -104.43%
Return On Investment Capital (ROIC_SIMPLE)
- - 10.49% 2.81% 4.00% -96.50%
Cost of Revenue to Revenue
66.68% 65.57% 64.88% 68.70% 65.36% 69.35%
SG&A Expenses to Revenue
37.11% 23.50% 23.47% 21.97% 22.51% 41.42%
R&D to Revenue
1.26% 1.04% 1.22% 1.74% 1.88% 4.21%
Operating Expenses to Revenue
48.97% 29.62% 30.17% 28.89% 29.99% 85.91%
Earnings before Interest and Taxes (EBIT)
-14 20 22 15 30 -186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.92 28 33 31 46 -170
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 4.26 2.66 1.93 1.35 0.60
Price to Tangible Book Value (P/TBV)
0.00 4.67 3.44 2.69 1.75 0.60
Price to Revenue (P/Rev)
0.00 2.94 1.65 0.93 0.70 0.27
Price to Earnings (P/E)
0.00 39.41 21.02 84.68 21.64 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 2.54% 4.76% 1.18% 4.62% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 14.55 4.69 2.03 1.44 0.07
Enterprise Value to Revenue (EV/Rev)
0.00 2.41 1.31 0.88 0.60 0.01
Enterprise Value to EBITDA (EV/EBITDA)
0.00 27.91 17.70 17.55 8.02 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 37.54 26.20 36.85 12.26 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 51.68 19.57 59.34 26.62 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 19.97 0.00 5.23 0.12
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 12.76 0.07
Leverage & Solvency
- - - - - -
Debt to Equity
0.02 0.01 0.01 0.08 0.10 0.03
Long-Term Debt to Equity
0.01 0.01 0.00 0.00 0.00 0.00
Financial Leverage
-0.47 -0.70 -0.65 -0.33 -0.15 -0.31
Leverage Ratio
1.50 1.39 1.39 1.51 1.53 1.53
Compound Leverage Factor
1.52 1.35 1.44 1.65 1.41 1.54
Debt to Total Capital
1.85% 0.84% 0.68% 7.59% 8.70% 2.54%
Short-Term Debt to Total Capital
0.97% 0.27% 0.24% 7.58% 8.69% 2.39%
Long-Term Debt to Total Capital
0.87% 0.57% 0.44% 0.01% 0.00% 0.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
17.52% 3.26% 2.03% 1.33% -1.66% -14.05%
Common Equity to Total Capital
80.64% 95.89% 97.29% 91.08% 92.97% 111.51%
Debt to EBITDA
-0.14 0.07 0.06 0.80 0.65 -0.02
Net Debt to EBITDA
3.49 -6.32 -4.79 -1.09 -1.29 0.37
Long-Term Debt to EBITDA
-0.07 0.05 0.04 0.00 0.00 0.00
Debt to NOPAT
-0.12 0.13 0.06 2.70 2.17 -0.03
Net Debt to NOPAT
3.02 -11.71 -5.30 -3.69 -4.29 0.51
Long-Term Debt to NOPAT
-0.06 0.09 0.04 0.00 0.00 0.00
Altman Z-Score
0.00 8.53 5.54 3.61 3.90 -1.49
Noncontrolling Interest Sharing Ratio
17.85% 6.61% 2.60% 1.72% -0.22% -5.41%
Liquidity Ratios
- - - - - -
Current Ratio
2.49 4.42 2.71 1.99 2.50 2.26
Quick Ratio
2.44 4.39 2.60 1.89 2.46 2.13
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2.19 -41 -139 29 57
Operating Cash Flow to CapEx
-260.81% -41.14% 903.53% -939.26% 1,975.92% 793.46%
Free Cash Flow to Firm to Interest Expense
0.00 -3.53 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-52.07 -3.14 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-72.03 -10.77 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.94 1.56 1.25 1.41 1.30 0.96
Accounts Receivable Turnover
3.79 6.17 4.86 3.42 2.61 2.12
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
10.33 29.19 25.92 32.78 38.88 21.89
Accounts Payable Turnover
12.35 18.59 14.66 20.72 16.73 11.32
Days Sales Outstanding (DSO)
96.42 59.12 75.14 106.72 140.00 172.08
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
29.55 19.64 24.90 17.62 21.82 32.24
Cash Conversion Cycle (CCC)
66.87 39.48 50.25 89.10 118.18 139.84
Capital & Investment Metrics
- - - - - -
Invested Capital
36 53 123 271 256 61
Invested Capital Turnover
2.63 7.19 5.01 3.17 2.34 2.12
Increase / (Decrease) in Invested Capital
0.00 17 70 148 -15 -182
Enterprise Value (EV)
0.00 769 577 551 368 4.13
Market Capitalization
0.00 936 727 581 433 86
Book Value per Share
$3.83 $2.19 $2.66 $2.90 $3.14 $1.47
Tangible Book Value per Share
$2.62 $2.00 $2.06 $2.07 $2.43 $1.47
Total Capital
68 229 281 330 345 129
Total Debt
1.26 1.93 1.90 25 30 3.28
Total Long-Term Debt
0.59 1.30 1.24 0.04 0.01 0.18
Net Debt
-31 -174 -156 -34 -59 -64
Capital Expenditures (CapEx)
4.09 4.73 3.20 6.84 3.56 4.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3.17 23 14 134 123 37
Debt-free Net Working Capital (DFNWC)
36 199 172 194 213 88
Net Working Capital (NWC)
35 198 171 169 183 85
Net Nonoperating Expense (NNE)
4.47 -4.30 -1.28 -0.76 0.45 72
Net Nonoperating Obligations (NNO)
-31 -174 -156 -34 -59 -65
Total Depreciation and Amortization (D&A)
5.51 7.07 11 16 16 15
Debt-free, Cash-free Net Working Capital to Revenue
3.37% 7.29% 3.24% 21.54% 20.02% 11.48%
Debt-free Net Working Capital to Revenue
37.83% 62.37% 38.95% 31.04% 34.50% 27.31%
Net Working Capital to Revenue
37.12% 62.17% 38.80% 27.03% 29.63% 26.35%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.30 $0.34 $0.07 $0.20 ($1.84)
Adjusted Weighted Average Basic Shares Outstanding
0.00 80.29M 101.23M 103.51M 102.40M 99.07M
Adjusted Diluted Earnings per Share
$0.00 $0.25 $0.34 $0.06 $0.18 ($1.84)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 94.86M 102.98M 105.62M 109.42M 99.07M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 100.17M 102.51M 104.17M 101.98M 98.75M
Normalized Net Operating Profit after Tax (NOPAT)
-7.71 19 21 17 32 -46
Normalized NOPAT Margin
-8.19% 5.86% 4.86% 2.78% 5.20% -14.20%
Pre Tax Income Margin
-15.55% 6.21% 5.17% 2.61% 4.50% -58.19%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-70.50 33.02 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-50.48 23.99 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-90.47 25.39 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-70.45 16.35 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 104.08% 0.00% 0.00% 23.52% -0.09%
Augmented Payout Ratio
0.00% 104.08% 12.20% 0.00% 126.48% -5.60%

Quarterly Metrics And Ratios for DocGo

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 101,982,549.00 99,104,331.00 97,808,137.00 97,813,372.00 98,750,251.00 98,778,413.00 98,928,369.00
DEI Adjusted Shares Outstanding
- - - - 101,982,549.00 99,104,331.00 97,808,137.00 97,813,372.00 98,750,251.00 98,778,413.00 98,928,369.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.09 -0.11 -0.28 -1.37 -0.15 -0.16 -0.17
Growth Metrics
- - - - - - - - - - -
Revenue Growth
69.98% 31.45% -25.66% -39.35% -50.01% -51.25% -48.94% -37.98% -21.33% -8.70% 3.70%
EBITDA Growth
758.07% 226.93% 4.21% -115.57% -151.95% -194.78% -382.76% -3,982.63% -32.50% -12.02% 59.95%
EBIT Growth
339.86% 1,720.52% 8.04% -148.61% -188.63% -271.85% -546.07% -1,766.48% -15.66% -2.32% 57.73%
NOPAT Growth
321.58% 190.14% 15.84% -168.38% -191.52% -296.89% -676.09% -1,299.40% -33.68% -2.53% 58.83%
Net Income Growth
370.58% 336.03% -1.83% -195.67% -204.49% -326.85% -752.45% -1,761.41% -50.73% -35.38% 38.32%
EPS Growth
433.33% 400.00% 0.00% -150.00% -190.00% -283.33% -660.00% -4,433.33% -66.67% -45.45% 39.29%
Operating Cash Flow Growth
53.98% 246.54% 167.64% 317.73% 186.63% -8.90% -94.67% -182.30% -150.54% -127.15% -318.28%
Free Cash Flow Firm Growth
29.08% 39.78% 95.88% 106.96% 140.29% 199.24% 1,294.47% 375.35% 342.94% 50.67% 49.46%
Invested Capital Growth
58.25% 44.70% 4.31% -5.54% -16.64% -32.82% -37.43% -74.96% -76.44% -70.48% -70.20%
Revenue Q/Q Growth
-3.59% -14.13% -15.92% -12.87% -20.52% -16.26% -11.95% 5.83% 0.82% -2.81% 0.01%
EBITDA Q/Q Growth
20.83% -29.52% -3.81% -119.01% -302.88% -28.60% -186.94% -174.62% 86.92% -8.72% -2.59%
EBIT Q/Q Growth
32.22% -37.27% -5.15% -161.79% -141.04% -21.61% -146.19% -158.64% 85.06% -7.59% -1.72%
NOPAT Q/Q Growth
39.94% -41.95% -17.93% -202.56% -87.30% -24.88% -140.14% -149.14% 82.11% 4.22% 3.56%
Net Income Q/Q Growth
32.65% -44.75% -22.41% -268.23% -44.89% -19.95% -123.16% -379.95% 88.27% -7.74% -1.67%
EPS Q/Q Growth
66.67% -40.00% -16.67% -160.00% -200.00% -22.22% -154.55% -385.71% 88.97% -6.67% -6.25%
Operating Cash Flow Q/Q Growth
-79.76% 448.28% -16.25% -58.47% -27.53% 248.04% -95.06% -731.04% 55.50% -98.41% 60.82%
Free Cash Flow Firm Q/Q Growth
27.79% 20.06% 92.77% 267.29% 77.76% 96.89% -12.94% 56.01% 65.64% -33.03% -13.64%
Invested Capital Q/Q Growth
12.21% -7.25% -5.89% -3.36% 4.16% -25.25% -12.35% -63.30% -2.01% -6.34% -11.52%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.03% 100.00% 100.00% -130.21% 100.00% 100.00% 100.00% -198.17% 100.00% 100.00% 100.00%
EBITDA Margin
10.60% 8.70% 9.95% -2.17% -11.01% -16.91% -55.11% -143.00% -18.55% -20.75% -21.28%
Operating Margin
8.26% 6.15% 7.31% -6.18% -14.58% -21.74% -59.28% -139.56% -24.77% -24.41% -23.54%
EBIT Margin
8.42% 6.15% 6.94% -4.92% -14.93% -21.68% -60.62% -148.14% -21.95% -24.30% -24.71%
Profit (Net Income) Margin
5.52% 3.55% 3.28% -6.33% -11.54% -16.53% -41.88% -189.95% -22.10% -24.50% -24.91%
Tax Burden Percent
67.44% 61.23% 50.31% 116.30% 74.85% 74.18% 68.70% 127.53% 100.12% 100.31% 100.46%
Interest Burden Percent
97.21% 94.31% 93.89% 110.58% 103.26% 102.77% 100.58% 100.54% 100.60% 100.55% 100.35%
Effective Tax Rate
32.56% 38.77% 49.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
15.84% 11.76% 9.85% -10.13% -19.09% -28.20% -70.95% -207.32% -33.47% -41.13% -45.55%
ROIC Less NNEP Spread (ROIC-NNEP)
16.03% 12.33% 10.99% -4.96% -14.87% -26.64% -70.59% -106.68% -26.31% -33.27% -35.60%
Return on Net Nonoperating Assets (RNNOA)
-2.78% -2.58% -1.74% 0.75% 1.46% 5.95% 18.68% 33.24% 6.41% 12.02% 13.05%
Return on Equity (ROE)
13.06% 9.18% 8.11% -9.38% -17.63% -22.25% -52.26% -174.08% -27.07% -29.10% -32.50%
Cash Return on Invested Capital (CROIC)
-35.25% -24.38% 7.28% 10.94% 17.85% 30.68% 19.73% 37.80% 41.86% 4.10% 5.02%
Operating Return on Assets (OROA)
13.19% 10.40% 10.55% -6.41% -16.86% -21.09% -52.64% -141.90% -20.69% -24.06% -27.85%
Return on Assets (ROA)
8.65% 6.01% 4.99% -8.25% -13.03% -16.07% -36.38% -181.95% -20.84% -24.27% -28.07%
Return on Common Equity (ROCE)
12.86% 9.08% 8.06% -9.41% -17.73% -22.50% -53.17% -183.51% -28.93% -31.59% -35.94%
Return on Equity Simple (ROE_SIMPLE)
7.89% 9.23% 8.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
11 6.21 5.10 -5.23 -9.80 -12 -29 -73 -13 -13 -12
NOPAT Margin
5.57% 3.77% 3.68% -4.33% -10.20% -15.22% -41.50% -97.69% -17.34% -17.09% -16.48%
Net Nonoperating Expense Percent (NNEP)
-0.20% -0.57% -1.14% -5.17% -4.22% -1.56% -0.35% -100.63% -7.16% -7.86% -9.95%
Return On Investment Capital (ROIC_SIMPLE)
- - - -1.52% -2.95% -3.85% -11.26% -56.68% -10.96% -12.08% -13.44%
Cost of Revenue to Revenue
64.98% 0.00% 0.00% 230.21% 0.00% 0.00% 0.00% 298.17% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
20.92% 21.07% 20.76% 29.00% 34.26% 38.85% 42.50% 52.33% 40.81% 40.51% 39.36%
R&D to Revenue
1.24% 1.44% 2.27% 3.05% 3.79% 3.68% 4.51% 5.03% 4.90% 4.69% 5.48%
Operating Expenses to Revenue
26.84% 93.85% 92.69% -124.15% 114.58% 121.74% 159.28% -58.61% 124.77% 124.41% 123.54%
Earnings before Interest and Taxes (EBIT)
16 10 9.62 -5.95 -14 -17 -43 -111 -17 -18 -18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
20 14 14 -2.62 -11 -14 -39 -107 -14 -15 -16
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.35 1.00 1.04 1.35 0.87 0.52 0.49 0.60 0.47 0.43 0.38
Price to Tangible Book Value (P/TBV)
1.85 1.35 1.40 1.75 1.16 0.71 0.63 0.60 0.47 0.43 0.38
Price to Revenue (P/Rev)
0.60 0.42 0.49 0.70 0.52 0.36 0.36 0.27 0.21 0.17 0.13
Price to Earnings (P/E)
19.48 10.43 11.02 21.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.13% 9.59% 9.07% 4.62% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.36 1.00 1.05 1.44 0.84 0.27 0.20 0.07 0.01 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.59 0.38 0.40 0.60 0.41 0.12 0.09 0.01 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
7.51 4.32 4.27 8.02 14.24 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
10.88 5.90 5.80 12.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
16.86 9.68 9.37 26.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 5.42 5.23 2.37 0.59 0.56 0.12 0.03 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 14.79 12.76 4.29 0.72 0.76 0.07 0.01 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.10 0.09 0.09 0.10 0.10 0.10 0.00 0.03 0.07 0.08 0.14
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.17 -0.21 -0.16 -0.15 -0.10 -0.22 -0.26 -0.31 -0.24 -0.36 -0.37
Leverage Ratio
1.50 1.46 1.48 1.53 1.49 1.48 1.45 1.53 1.55 1.55 1.55
Compound Leverage Factor
1.46 1.38 1.39 1.69 1.54 1.52 1.46 1.53 1.56 1.56 1.56
Debt to Total Capital
8.71% 8.63% 8.47% 8.70% 9.04% 9.45% 0.10% 2.54% 6.96% 7.80% 12.30%
Short-Term Debt to Total Capital
8.70% 8.63% 8.46% 8.69% 9.04% 9.45% 0.02% 2.39% 6.82% 7.65% 12.13%
Long-Term Debt to Total Capital
0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.08% 0.14% 0.14% 0.15% 0.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.09% 0.81% -0.09% -1.66% -2.23% -3.00% -3.78% -14.05% -17.65% -22.40% -28.99%
Common Equity to Total Capital
90.20% 90.55% 91.62% 92.97% 93.19% 93.56% 103.69% 111.51% 110.69% 114.60% 116.70%
Debt to EBITDA
0.55 0.46 0.46 0.65 2.01 -2.31 0.00 -0.02 -0.05 -0.05 -0.07
Net Debt to EBITDA
-0.21 -0.56 -0.92 -1.29 -3.28 7.25 1.38 0.37 0.23 0.19 0.16
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
1.23 1.04 1.01 2.17 -36.21 -1.49 0.00 -0.03 -0.07 -0.06 -0.10
Net Debt to NOPAT
-0.48 -1.26 -2.01 -4.29 59.11 4.67 1.60 0.51 0.32 0.26 0.22
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
3.38 3.12 3.12 3.64 2.75 2.03 1.70 -0.35 0.58 0.30 -0.04
Noncontrolling Interest Sharing Ratio
1.50% 1.15% 0.59% -0.22% -0.59% -1.11% -1.74% -5.41% -6.90% -8.56% -10.59%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.09 2.13 2.19 2.50 2.44 2.36 2.59 2.26 1.79 1.66 1.38
Quick Ratio
2.03 2.10 2.15 2.46 2.40 2.27 2.45 2.13 1.68 1.54 1.28
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-101 -81 -5.84 9.77 41 80 70 109 180 121 104
Operating Cash Flow to CapEx
-1,148.13% 3,235.64% 4,495.30% 1,616.12% 985.45% 5,424.22% 193.93% -701.06% -1,140.48% -3,099.40% -167.35%
Free Cash Flow to Firm to Interest Expense
-273.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-28.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-31.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.57 1.69 1.52 1.30 1.13 0.97 0.87 0.96 0.94 0.99 1.13
Accounts Receivable Turnover
3.39 3.95 3.15 2.61 2.25 2.29 2.16 2.12 2.21 2.82 3.13
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
36.98 39.16 37.43 38.88 33.19 28.66 24.88 21.89 21.03 21.72 23.08
Accounts Payable Turnover
24.80 29.54 19.15 16.73 17.47 19.69 18.66 11.32 13.00 18.51 17.87
Days Sales Outstanding (DSO)
107.61 92.38 115.82 140.00 161.95 159.18 168.93 172.08 164.96 129.40 116.62
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
14.72 12.36 19.06 21.82 20.90 18.53 19.56 32.24 28.09 19.72 20.43
Cash Conversion Cycle (CCC)
92.89 80.02 96.76 118.18 141.05 140.64 149.37 139.84 136.88 109.68 96.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
303 281 265 256 253 189 166 61 60 56 49
Invested Capital Turnover
2.84 3.12 2.68 2.34 1.87 1.85 1.71 2.12 1.93 2.41 2.76
Increase / (Decrease) in Invested Capital
112 87 11 -15 -50 -92 -99 -182 -193 -133 -116
Enterprise Value (EV)
412 280 279 368 213 52 32 4.13 0.55 -5.32 -11
Market Capitalization
420 314 340 433 269 156 133 86 62 51 40
Book Value per Share
$3.00 $3.10 $3.18 $3.14 $3.03 $3.00 $2.77 $1.47 $1.34 $1.21 $1.06
Tangible Book Value per Share
$2.19 $2.28 $2.37 $2.43 $2.28 $2.23 $2.16 $1.47 $1.33 $1.19 $1.04
Total Capital
345 348 355 345 332 318 261 129 120 104 90
Total Debt
30 30 30 30 30 30 0.25 3.28 8.32 8.11 11
Total Long-Term Debt
0.03 0.03 0.02 0.01 0.00 0.00 0.20 0.18 0.17 0.16 0.15
Net Debt
-12 -37 -60 -59 -49 -94 -91 -64 -40 -33 -24
Capital Expenditures (CapEx)
0.93 1.15 0.69 0.80 0.94 0.62 0.86 1.49 0.41 0.30 2.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
164 139 119 123 106 62 43 37 33 30 22
Debt-free Net Working Capital (DFNWC)
205 205 208 213 185 166 117 88 69 55 41
Net Working Capital (NWC)
175 175 178 183 155 136 117 85 61 47 30
Net Nonoperating Expense (NNE)
0.10 0.36 0.55 2.42 1.28 1.05 0.27 69 3.60 5.45 6.19
Net Nonoperating Obligations (NNO)
-12 -37 -60 -59 -49 -99 -95 -65 -52 -40 -30
Total Depreciation and Amortization (D&A)
4.18 4.20 4.18 3.32 3.76 3.84 3.90 3.85 2.57 2.61 2.52
Debt-free, Cash-free Net Working Capital to Revenue
23.28% 18.65% 17.07% 20.02% 20.36% 14.28% 11.77% 11.48% 11.08% 10.24% 7.36%
Debt-free Net Working Capital to Revenue
29.15% 27.55% 29.95% 34.50% 35.54% 38.18% 31.70% 27.31% 22.90% 18.80% 13.78%
Net Working Capital to Revenue
24.88% 23.50% 25.63% 29.63% 29.77% 31.29% 31.69% 26.35% 20.20% 16.10% 10.11%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.11 $0.06 $0.05 ($0.02) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15) ($0.16) ($0.17)
Adjusted Weighted Average Basic Shares Outstanding
103.82M 101.84M 102.07M 102.40M 101.59M 98.93M 97.81M 99.07M 98.75M 98.80M 98.94M
Adjusted Diluted Earnings per Share
$0.10 $0.06 $0.05 ($0.03) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15) ($0.16) ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding
108.51M 106.32M 106.29M 109.42M 101.59M 98.93M 97.81M 99.07M 98.75M 98.80M 98.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
101.57M 102.32M 102.05M 101.98M 99.10M 97.81M 97.81M 98.75M 98.78M 98.93M 98.99M
Normalized Net Operating Profit after Tax (NOPAT)
14 8.67 6.76 -1.36 -6.85 -9.19 -14 -67 -9.57 -9.73 -8.08
Normalized NOPAT Margin
7.09% 5.26% 4.87% -1.13% -7.13% -11.43% -19.29% -88.79% -12.67% -13.25% -11.00%
Pre Tax Income Margin
8.19% 5.80% 6.51% -5.44% -15.41% -22.28% -60.96% -148.94% -22.08% -24.43% -24.80%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
43.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
29.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
41.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
26.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 23.52% 0.00% -10.53% -1.98% -0.09% -0.59% -0.58% -1.11%
Augmented Payout Ratio
19.85% 33.63% 38.20% 126.48% -175.81% -64.42% -23.88% -5.60% -3.11% -0.58% -1.11%

Financials Breakdown Chart

Key Financial Trends

DocGo’s financial profile has weakened substantially from 2023 and early 2024 levels. Quarterly revenue declined from $199.2 million in Q4 2023 and $192.1 million in Q1 2024 to $73.4 million in Q2 2026. Revenue has stabilized near $70 million to $76 million over the past four quarters, but the company has not yet returned to profitability.

  • Debt has been reduced significantly. Short-term debt fell to $7.9 million in Q2 2026 from approximately $30.0 million in Q2 2025, while long-term debt was only $0.2 million. This limits interest-rate and refinancing risk.
  • Accounts receivable has declined sharply. Receivables fell to $86.2 million in Q2 2026 from $257.5 million in Q2 2024, which may indicate improved collections and less capital tied up in customer balances.
  • DocGo maintained a reasonable current liquidity position. Cash and equivalents totaled $25.2 million, and current assets of $119.8 million exceeded current liabilities of $72.3 million, producing a current ratio of approximately 1.7.
  • Operating expenses were modestly lower sequentially. Total operating expenses declined to $91.3 million in Q2 2026 from $94.3 million in Q1, while selling, general and administrative expense decreased by about 3.5%.
  • Revenue appears to be stabilizing at a much lower level. Revenue of $73.4 million in Q2 2026 was down from $75.6 million in Q1 but broadly consistent with the $70.8 million reported in Q3 2025 and $74.9 million in Q4 2025.
  • The balance sheet remains heavily dependent on equity. DocGo reported $119.1 million of common equity, but retained earnings were negative $214.4 million. Total equity and noncontrolling interests were $95.8 million after a negative $23.3 million noncontrolling interest balance.
  • DocGo remains unprofitable. Q2 2026 operating loss was $17.9 million, consolidated net loss was $18.0 million, and the loss attributable to common shareholders was $15.8 million, or $0.16 per diluted share.
  • Cash flow from operations has deteriorated. Operating cash flow was negative $9.2 million in Q2 2026 after negative $4.7 million in Q1. This compares with positive operating cash flow of $33.6 million in Q2 2025 and $31.0 million in Q3 2024.
  • Cash reserves have been steadily depleted. Cash fell from $169.6 million in Q3 2022 and $104.2 million in Q2 2025 to $25.2 million in Q2 2026. Cash declined by $14.6 million during Q2 alone, after falling by $5.7 million in Q1.
  • Profitability trends remain a major concern. DocGo moved from positive net income in 2023 and early 2024 to recurring losses throughout 2025 and 2026. The company also recorded unusually large special charges and other operating expenses in several periods, making the path to sustainable earnings difficult to assess.

For investors, the most important issue is whether DocGo can convert its lower revenue base into consistent positive operating cash flow. Reduced debt and lower receivables provide some financial support, but the ongoing losses and cash burn could eventually require additional cost reductions, asset sales or external financing if operating performance does not improve.

Note: The supplied filings include restated periods and unusual classifications, including zero reported cost of revenue in several 2025 and 2026 quarters despite substantial operating expenses. Investors should review the company’s latest filings and footnotes before comparing gross margins or other profitability ratios across periods.

11/17/26 04:45 PM ETAI Generated. May Contain Errors.

DocGo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, DocGo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

DocGo's net income appears to be on a downward trend, with a most recent value of -$196.37 million in 2025, falling from -$14.80 million in 2020. The previous period was $13.36 million in 2024. See DocGo's forecast for analyst expectations on what's next for the company.

DocGo's total operating income in 2025 was -$178.03 million, based on the following breakdown:
  • Total Gross Profit: $98.76 million
  • Total Operating Expenses: $276.79 million

Over the last 5 years, DocGo's total revenue changed from $94.09 million in 2020 to $322.20 million in 2025, a change of 242.4%.

In the past 13 quarters, DocGo's cash and equivalents has ranged from $19.11 million in Q3 2026 to $109.16 million in Q2 2023, and is currently $19.11 million as of their latest financial filing in Q3 2026.

DocGo had total debt of $3.28 million at the end of 2025, a 89.1% decrease from 2024, and a 160.2% increase since 2020.

Over the last 5 years, DocGo's book value per share changed from 3.83 in 2020 to 1.47 in 2025, a change of -61.5%.



Financial statements for NASDAQ:DCGO last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners